FDA will submit
full Supporting Statements A and B for each individual Gen IC
submission. The supporting statements must describe the specific
purpose of the collection, including the way that the resulting
data will be analyzed and used (i.e., identify the activity that
the developmental work will inform, and broader purpose of the
activity that is being informed by the developmental work being
conducted in the particular Gen IC). When incentives are used, FDA
will provide a thorough justification. Information gathered will
not be used for the purpose of substantially informing influential
policy decisions, are intended to inform pretesting of tobacco
communication messages and other materials directed at consumers,
and are not intended to yield results that are statistically
projectable, nationally representative, or precise estimates of
population parameters
Inventory as of this Action
Requested
Previously Approved
11/30/2018
11/30/2018
11/30/2018
83,063
0
21,600
9,430
0
7,128
0
0
0
The Food and Drug Administration (FDA)
is requesting approval of a new generic for collecting information
through the use of quantitative methods for studies about tobacco
products. FDA will need to employ quantitative research, including
surveys and experimental studies to assess knowledge and
perceptions about tobacco-related topics with specific target
audiences. FDA will only submit an individual generic collection
for approval under this generic clearance if the individual
collection meets the outlined conditions.
PL:
Pub.L. 111 - 111 31 Name of Law: Family Smoking Prevention and
Tobacco Control Act
US Code: 21
USC 372 Name of Law: Federal Food, Drug, and Cosmetic Act
US Code:
21 USC 393(d)(2)(D) Name of Law: Federal Food, Drug, and
Cosmetic Act
US Code: 42
USC 241(a) Name of Law: Public Health Service Act
US Code: 21
USC 355 Name of Law: Federal Food, Drug, and Cosmetic Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.